New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
19:03 EDTAGEN, IDIX, ARWR, HAIN, OCLR, IDRA, CHRW, MYGN, MMM, GNWOn The Fly: After Hours Movers
UP AFTER EARNINGS: Myriad Genetics (MYGN), up 14.5%... Genworth (GNW), up 5%... Oclaro (OCLR), up 5.6%. ALSO HIGHER: 3M (MMM), up 2% after the Dow member announced a $12B share repurchase plan... Idenix Pharmaceuticals (IDIX), up 7.3% after investment firm Baupost Group raised its stake in the company to more than 35% from roughly 27% and disclosed it was granted observer rights for meetings of Idenix's board and committees. DOWN AFTER EARNINGS: C.H. Robinson (CHRW), down 6.4%... Hain Celestial (HAIN), down 7.9%. ALSO LOWER: Agenus (AGEN), down 6.2% after announcing a public offering of common stock... Idera Pharmaceuticals (IDRA), down 3.8% after filing to sell common stock and warrants... Arrowhead Research (ARWR), down 3% after reporting a larger-than-expected quarterly loss and filing a $200M mixed securities shelf.
News For MMM;MYGN;GNW;OCLR;IDIX;CHRW;HAIN;AGEN;IDRA;ARWR From The Last 14 Days
Check below for free stories on MMM;MYGN;GNW;OCLR;IDIX;CHRW;HAIN;AGEN;IDRA;ARWR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
15:35 EDTMMMNotable companies reporting before tomorrow's open
Subscribe for More Information
11:38 EDTHAINWhiteWave Foods rises after analyst sees significant growth promise
Subscribe for More Information
07:47 EDTMMM3M Company April weekly volatility elevated into Q1 and growth outlook
Subscribe for More Information
05:17 EDTGNWGenworth file prospectus for Australian IPO
Subscribe for More Information
April 22, 2014
12:00 EDTIDRAIdera Pharmaceuticals rises 16.2%
Idera Pharmaceuticals is up 16.2%, or 46c, to $3.30
April 16, 2014
08:17 EDTMMM3M against proposal for shareholder actions without vote first, Reuters says
3M Company said its board opposed a proposal by shareholder James McRitchie to allow investors with a certain amount of shares to take a specific action through written consent without voting first, according to Reuters, citing a company letter to stockholders. Reference Link
April 14, 2014
15:29 EDTCHRWC.H. Robinson May volatility elevated at 29 on sharp three-day rally
Subscribe for More Information
14:42 EDTARWRAlnylam slips after Novartis reportedly cuts back RNAi development
Subscribe for More Information
April 11, 2014
12:42 EDTCHRWOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:53 EDTCHRWC.H. Robinson upgraded to Buy from Hold at BB&T
April 10, 2014
09:20 EDTCHRWC.H. Robinson margins improving, says Cleveland Research
Cleveland Research's checks indicate C.H. Robinson's margins have improved due to increased volumes of spot/transactional freight and shippers accepting rate increases. The firm remains slightly below consensus for Q1 earnings estimates and slightly above consensus for Q2.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use